Prescription Drugs Effects of Unapproved Colchicine Effective But off Market, FDA Says
Prescription Drugs Effects - the FDA has issued orders to stop shipments of the unapproved medication, colchicines, within the next three months. The FDA’s decision to halt the popular gout treatment medication comes after Philadelphia company URL Pharma won exclusive selling rights for its colchicine product, Colcrys, which treats gout pain.
